Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VOXAR 3D ENTERPRISE, MODEL 6.1

K-Number: K060505 · 2006-03-29

ApplicantBarcoview Mis Edinburgh
Decision Date2006-03-29
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

VOXAR 3D ENTERPRISE, MODEL 6.1 is the device name listed in this FDA 510(k) record. The listed applicant is Barcoview Mis Edinburgh. It received FDA 510(k) clearance on 2006-03-29 under 510(k) number K060505. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VOXAR 3D ENTERPRISE, MODEL 6.1?

VOXAR 3D ENTERPRISE, MODEL 6.1 is a medical device that received FDA 510(k) clearance on 2006-03-29. The listed applicant is Barcoview Mis Edinburgh. The 510(k) number is K060505.

When did VOXAR 3D ENTERPRISE, MODEL 6.1 receive FDA 510(k) clearance?

VOXAR 3D ENTERPRISE, MODEL 6.1 received FDA 510(k) clearance on 2006-03-29, under 510(k) number K060505.

Who is the listed applicant for VOXAR 3D ENTERPRISE, MODEL 6.1?

The FDA 510(k) record lists Barcoview Mis Edinburgh as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VOXAR 3D ENTERPRISE, MODEL 6.1?

The FDA product code for VOXAR 3D ENTERPRISE, MODEL 6.1 is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Barcoview Mis Edinburgh as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K070831VOXAR 3D ENTERPRISE WITH COLONMETRIX AND PET/CT PERFUSIONK061326VOXAR 3D ENTERPRISE WITH CARDIAMETRIX

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261874Syneris PACS v.1.0.1.0SynerisK262442HipStudio AnalysisReplasia BVK261855Elucid PlaqueIQElucid Bioimaging, Inc.K254214OOOPDSTaiwan Main Orthopaedic Biotechnology Co., Ltd.K261861SPINEsim v1.0Mdsim S.A.K2620603D-RD-SRadiopharmaceutical Imaging & Dosimetry, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑